/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Human Genome Sciences Inc. (HGSI) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 27.06\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n  \n\n 1.30\n\n (+5.05%)\n\n \n\n \n\n \n\n \n\n Volume: 4.3 m\n\n \n\n \n\n\n\n 4:00 PM EST Feb 9, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n
\n \n \n \n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n\n
\n After Hours: \n $ 27.06 \n \n \n \n 0.00\n (0.00%)\n \n \n \n \n Volume: 151.02 k\n \n \n \n6:46 PM EST Feb 9, 2010\n\n \n
\n
\n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
January 05,2010
\n \n
Close: \n 32.07\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
March 11,2009
\n \n
Close: \n 0.45\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
27.06
\n 		\n\n \n \n \n
Change $
\n \n 1.30\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 5.05%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
27.15
\n 		\n \n \n \n\n
Bid Size
100
\n 		\n \n \n \n
Ask
27.15
\n\n 		\n \n \n \n
Ask Size
100
\n
\n \n \n \n
Open
26.12
\n 		\n \n \n \n
High
27.19
\n 		\n\n \n \n \n
Low
26.06
\n 		\n \n\n \n \n
Prev Close
25.76
\n
\n \n\n \n \n
Last Trade
4:00
\n 		\n \n \n \n
Volume
4.3 m
\n 		\n \n \n \n
\n
52 Wk Hi
32.07
\n 		\n\n \n \n \n
52 Wk Low
0.45
\n
\n \n\n \n \n
Market Cap
4.47 b
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
165,011,468
\n 		\n \n \n \n
EPS (TTM)
-0.36
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
NASDAQ (NSD)
\n
\n
\n
\n
\n
\n \n
Exchange
NSD
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Human Genome Sciences Inc.\n\n \n\n  (HGSI) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for HGSI\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Feb 05, 2010
\n\n \n\n\n\n
8:00 AM\n\n\n\n Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BIO CEO Investor Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Feb 01, 2010
\n\n \n\n\n\n
7:00 AM\n\n\n\n Human Genome Sciences Names Scott Habig Vice President, Sales - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jan 20, 2010
\n\n \n\n\n\n
2:05 PM\n\n\n\n Stock-PR.com Announces Stock Watch Alert: HGSI - World Stock Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jan 06, 2010
\n\n \n\n\n\n
4:05 PM\n\n\n\n Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 15, 2009
\n\n \n\n\n\n
7:00 AM\n\n\n\n Human Genome Sciences Announces Submission of Marketing Authorization Application to EMEA for JOULFERON(R) (ZALBIN(TM)) - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Dec 11, 2009
\n\n \n\n\n\n
8:08 PM\n\n\n\n Quarterly Changes to the NASDAQ Q-50 Index - GlobeNewswire
8:40 AM\n\n\n\n Research and Markets: Human Genome Sciences Inc: A Complete And Comprehensive Analysis - Business Wire
8:00 AM\n\n\n\n Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Dec 09, 2009
\n\n \n\n\n\n
9:14 AM\n\n\n\n FYI from Human Genome Sciences: GSK Initiates Second Pivotal Phase 3 Trial for Investigational Cardiovascular Medication Darapladib - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 08, 2009
\n\n \n\n\n\n
11:47 AM\n\n\n\n Human Genome Sciences Announces Closing of Public Offering of Common Stock - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Dec 03, 2009
\n\n \n\n\n\n
6:52 AM\n\n\n\n The Fortune Financial Reviews Equities Within Consumer Goods, Basic Materials, Financial, Technology and Healthcare Sectors - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Dec 02, 2009
\n\n \n\n\n\n
9:07 PM\n\n\n\n Human Genome Sciences Announces Pricing of Public Offering of Common Stock - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 30, 2009
\n\n \n\n\n\n
4:01 PM\n\n\n\n Human Genome Sciences Announces Proposed Public Offering of Common Stock - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 25, 2009
\n\n \n\n\n\n
1:07 PM\n\n\n\n The Lupus Foundation of America Hosts Special Webinar to Discuss BENLYSTA(TM) Results - PR Newswire
7:01 AM\n\n\n\n Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN(TM) - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 23, 2009
\n\n \n\n\n\n
7:00 AM\n\n\n\n Human Genome Sciences and Aegera Therapeutics Announce Initiation of Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Lymphoid Tumors - Business Wire
6:39 AM\n\n\n\n Ridgewater Equity Reviews the Following Equities Human Genome Sciences Inc., Intuit Inc., Advanced Battery Technologies, Linn Energy LLC, Intel Corp. and Allos Therapeutics Inc. - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Nov 19, 2009
\n\n \n\n\n\n
10:33 AM\n\n\n\n Aegera Thérapeutique débute une étude randomisée de phase 2B portant sur son composé AEG35156 destiné au traitement de la leucémie myéloïde aiguë (LMA) - CNW
9:41 AM\n\n\n\n Aegera Thérapeutique débute une étude randomisée de phase 2B portant sur son composé AEG35156 destiné au traitement de la leucémie myéloïde aiguë (LMA) - CNW
9:40 AM\n\n\n\n Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) - CNW
\n\n More News for HGSI >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");